References
Key articles
US Preventive Services Task Force; Barry MJ, Nicholson WK, Silverstein M, et al. Folic acid supplementation to prevent neural tube defects: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2023 Aug 1;330(5):454-9. Abstract
Douglas Wilson R, Van Mieghem T, Langlois S, et al. Guideline no. 410: prevention, screening, diagnosis, and pregnancy management for fetal neural tube defects. J Obstet Gynaecol Can. 2021 Jan;43(1):124-39.e8. Abstract
Spina Bifida Association. Guidelines for the care of people with spina bifida. 2018 [internet publication].Full text
Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011 Mar 17;364(11):993-1004.Full text Abstract
Reference articles
1. Shurtleff DB, Lemire R, Warkany J. Embryology, etiology, and epidemiology. In: Shurtleff BD, ed. Myelodysplasias and exstrophies: significance, prevention, and treatment. Orlando, FL: Grune & Statton; 1986:39-64.
2. Ozek MM, Cinalli G, Maixner VJ, eds. Spina bifida management and outcome. Milan, Italy: Springer Press; 2008.
3. Mai CT, Isenburg JL, Canfield MA, et al. National population-based estimates for major birth defects, 2010-2014. Birth Defects Res. 2019 Nov 1;111(18):1420-35.Full text Abstract
4. Mitchell LE. Epidemiology of neural tube defects. Am J Med Genet C Semin Med Genet. 2005 May 15;135C(1):88-94.Full text Abstract
5. Centers for Disease Control and Prevention. Racial/ethnic differences in the birth prevalence of spina bifida - United States, 1995-2005. MMWR Morb Mortal Wkly Rep. 2009 Jan 9;57(53):1409-13.Full text Abstract
6. Shin M, Besser LM, Siffel C, et al; Congenital Anomaly Multistate Prevalence and Survival Collaborative. Prevalence of spina bifida among children and adolescents in 10 regions in the United States. Pediatrics. 2010 Aug;126(2):274-9. Abstract
7. Sebold CD, Melvin EC, Siegel D, et al. Recurrence risks for neural tube defects in siblings of patients with lipomyelomeningocele. Genet Med. 2005 Jan;7(1):64-7. Abstract
8. Cowchock S, Ainbender E, Prescott G, et al. The recurrence risk for neural tube defects in the United States: a collaborative study. Am J Med Genet. 1980;5(3):309-14. Abstract
9. Copp AJ, Adzick NS, Chitty LS, et al. Spina bifida. Nat Rev Dis Primers. 2015 Apr 30;1:15007.Full text Abstract
10. Carter CO, Roberts JA. The risk of recurrence after two children with central-nervous-system malformations. Lancet. 1967 Feb 11;1(7485):306-8. Abstract
11. Nevin NC, Johnston WP. Risk of recurrence after two children with central nervous system malformations in an area of high incidence. J Med Genet. 1980 Apr;17(2):87-92.Full text Abstract
12. GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024 Apr;23(4):344-81.Full text Abstract
13. Olney RS, Mulinare J. Trends in neural tube defect prevalence, folic acid supplementation, and vitamin supplement use. Semin Perinatol. 2002 Aug;26(4):277-85. Abstract
14. Greene WB, Terry RC, Demasi RA, et al. Effect of race and gender on neurological level in myelomeningocele. Dev Med Child Neurol. 1991 Feb;33(2):110-7. Abstract
15. Nikkilä A, Rydhström H, Källén B. Incidence of spina bifida in Sweden 1973-2003: the effect of prenatal diagnosis. Eur J Public Health. 2006 Dec;16(6):660-2.Full text Abstract
16. Cragan JD, Robert HE, Edmonds LD, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis - United States, 1985-1994. MMWR CDC Surveill Summ. 1995 Aug 25;44(4):1-13.Full text Abstract
17. Williams J, Mai CT, Mulinare J, et al. Updated estimates of neural tube defects prevented by mandatory folic acid fortification - United States, 1995-2011. MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):1-5.Full text Abstract
18. De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007 Jul 12;357(2):135-42.Full text Abstract
19. Boulet SL, Yang Q, Mai C, et al. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol. 2008 Jul;82(7):527-32. Abstract
20. Field MS, Stover PJ. Safety of folic acid. Ann N Y Acad Sci. 2018 Feb;1414(1):59-71.Full text Abstract
21. Weggemans RM, Schaafsma G, Kromhout D, et al. Toward an optimal use of folic acid: an advisory report of the Health Council of the Netherlands. Eur J Clin Nutr. 2009 Aug;63(8):1034-6.Full text Abstract
22. Morris MS, Jacques PF, Rosenberg IH, et al. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr. 2007 Jan;85(1):193-200.Full text Abstract
23. Moazzen S, Dolatkhah R, Tabrizi JS, et al. Folic acid intake and folate status and colorectal cancer risk: a systematic review and meta-analysis. Clin Nutr. 2018 Dec;37(6 pt a):1926-34. Abstract
24. Khalighi Sikaroudi M, Soltani S, Kolahdouz-Mohammadi R, et al. The association between dietary folate intake and risk of colorectal cancer incidence: a systematic review and dose‒response meta-analysis of cohort studies. Heliyon. 2024 Jul 15;10(13):e33564.Full text Abstract
25. Moore LL, Singer MR, Bradlee ML, et al. A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology. 2000 Nov;11(6):689-94. Abstract
26. Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diab Med. 2002 Apr;19(4):322-6. Abstract
27. Watkins ML, Rasmussen SA, Honein MA, et al. Maternal obesity and risk for birth defects. Pediatrics. 2003 May;111(5 Pt 2):1152-8. Abstract
28. Shaw GM, Quach T, Nelson V, et. al. Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr. 2003 Nov;78(5):972-8. Abstract
29. Mitchell LE, Adzick NS, Melchionne J, et al. Spina bifida. Lancet. 2004 Nov 20-26;364(9448):1885-95. Abstract
30. Canfield MA, Ramadhani TA, Shaw GM. Anencephaly and spina bifida among Hispanics: maternal, sociodemographic, and acculturation factors in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol. 2009 Jul;85(7):637-46. Abstract
31. Au KS, Tran PX, Tsai CC, et al. Characteristics of a spina bifida population including North American Caucasian and Hispanic individuals. Birth Defects Res A Clin Mol Teratol. 2008 Oct;82(10):692-700.Full text Abstract
32. Hall JG, Solehdin F. Genetics of neural tube defects. Ment Retard Dev Disabil Res Rev. 1998;4:269-81.
33. Lee S, Gleeson JG. Closing in on mechanisms of open neural tube defects. Trends Neurosci. 2020 Jul;43(7):519-32.Full text Abstract
34. Ornoy A. Neuroteratogens in man: an overview with special emphasis on the teratogenicity of anti-epileptic drugs in pregnancy. Reprod Toxicol. 2006 Aug;22(2):214-26. Abstract
35. Lloyd ME, Carr M, McElhatton P. The effects of methotrexate on pregnancy, fertility and lactation. QJM. 1999 Oct;92(10):551-63.Full text Abstract
36. Becerra JE, Khoury MJ, Cordero JF, et al. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based care-control study. Pediatrics. 1990 Jan;85(1):1-9. Abstract
37. Wasserman CR, Shaw GM, Selvin S, et al. Socioeconomic status, neighborhood social conditions, and neural tube defects. Am J Public Health. 1998 Nov;88(11):1674-80.Full text Abstract
38. Suarez L, Felker M, Hendricks K. The effect of fever, febrile illnesses, and heat exposure on the risk of neural tube defects in a Texas-Mexico population. Birth Defects Res A Clin Mol Teratol. 2004 Oct;70(10):815-9. Abstract
39. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child. 1976 Dec;51(12):944-50.Full text Abstract
40. Smithells RW, Nevin NC, Seller MJ, et al. Further experience of vitamin supplementation for prevention of neural tube defect occurrence. Lancet. 1983 May 7;1(8332):1027-31. Abstract
41. Mulinare J, Cordero JF, Erickson JD, et al. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988 Dec 2;260(21):3141-5. Abstract
42. Bell KN, Oakley GP Jr. Update on prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol. 2009 Jan;85(1):102-7. Abstract
43. Wahbeh F, Manyama M. The role of vitamin B12 and genetic risk factors in the etiology of neural tube defects: a systematic review. Int J Dev Neurosci. 2021 Aug;81(5):386-406. Abstract
44. Boyles AL, Hammock P, Speer MC. Candidate gene analysis in human neural tube defects. Am J Med Genet C Semin Med Genet. 2005 May 15;135C(1):9-23.Full text Abstract
45. Williams H. A unifying hypothesis for hydrocephalus, Chiari malformation, syringomyelia, anencephaly and spina bifida. Cerebrospinal Fluid Res. 2008 Apr 11;5:7.Full text Abstract
46. de Wit OA, den Dunnen WF, Sollie KM, et al. Pathogenesis of cerebral malformations in human fetuses with meningomyelocele. Cerebrospinal Fluid Res. 2008 Mar 1;5:4.Full text Abstract
47. Hasan KM, Eluvathingal TJ, Kramer LA, et al. White matter microstructural abnormalities in children with spina bifida myelomeningocele and hydrocephalus: a diffusion tensor tractography study of the association pathways. J Magn Reson Imaging. 2008 Apr;27(4):700-9.Full text Abstract
48. Greene ND, Stanier P, Copp AJ. Genetics of human neural tube defects. Hum Mol Genet. 2009 Oct 15;18(R2):R113-29.Full text Abstract
49. Ross ME. Gene-environment interactions, folate metabolism and the embryonic nervous system. Wiley Interdiscip Rev Syst Biol Med. 2010 Jul-Aug;2(4):471-80.Full text Abstract
50. US Preventive Services Task Force; Barry MJ, Nicholson WK, Silverstein M, et al. Folic acid supplementation to prevent neural tube defects: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2023 Aug 1;330(5):454-9. Abstract
51. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet. 1991 Jul 20;338(8760):131-7. Abstract
52. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992 Sep 11;41(RR-14):1-7.Full text Abstract
53. Chen CP. Syndromes, disorders and maternal risk factors associated with neural tube defects (I). Taiwan J Obstet Gynecol. 2008 Mar;47(1):1-9.Full text Abstract
54. Melvin EC, George TM, Worley G, et al. Genetic studies in neural tube defects. NTD Collaborative Group. Pediatr Neurosurg. 2000 Jan;32(1):1-9. Abstract
55. Hall JG, Friedman JM, Kenna BA, et al. Clinical, genetic, and epidemiological factors in neural tube defects. Am J Hum Genet. 1988 Dec;43(6):827-37.Full text Abstract
56. Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009 Apr 16;360(16):1597-605. Abstract
57. Stothard KJ, Tennant PW, Bell R, et al. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA. 2009 Feb 11;301(6):636-50. Abstract
58. Chen CP. Maternal diabetes and neural tube defects: prenatal diagnosis of lumbosacral myelomeningocele, ventriculomegaly, Arnold-Chiari malformation, and foot deformities in a pregnancy with poor maternal metabolic control, and review of the literature. Genet Couns. 2005;16(3):313-6. Abstract
59. Suarez L, Hendricks K, Felkner M, et al. Maternal serum vitamin B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol. 2003 Feb;13(2):81-8. Abstract
60. American College of Obstetricians and Gynecologists. Practice bulletin no. 187: neural tube defects. Obstet Gynecol. 2017 Dec;130(6):e279-90. Abstract
61. Douglas Wilson R, Van Mieghem T, Langlois S, et al. Guideline no. 410: prevention, screening, diagnosis, and pregnancy management for fetal neural tube defects. J Obstet Gynaecol Can. 2021 Jan;43(1):124-39.e8. Abstract
62. Centers for Disease Control and Prevention (CDC). Spina bifida and anencephaly before and after folic acid mandate - United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep. 2004 May 7;53(17):362-5.Full text Abstract
63. Centeno Tablante E, Pachón H, Guetterman HM, et al. Fortification of wheat and maize flour with folic acid for population health outcomes. Cochrane Database Syst Rev. 2019 Jul 1;(7):CD012150.Full text Abstract
64. Lary JM, Edmonds LD. Prevalence of spina bifida at birth - United States, 1983-1990: a comparison of two surveillance systems. MMWR CDC Surveill Summ. 1996 Apr 19;45(2):15-26.Full text Abstract
65. World Health Organization. Guideline: fortification of wheat flour with vitamins and minerals as a public health strategy. Jun 2022 [internet publication].Full text
66. Kancherla V, Botto LD, Rowe LA, et al. Preventing birth defects, saving lives, and promoting health equity: an urgent call to action for universal mandatory food fortification with folic acid. Lancet Glob Health. 2022 Jul;10(7):e1053-7.Full text Abstract
67. World Health Organization. World Health Assembly Resolution WHA 76-19. Accelerating efforts for preventing micronutrient deficiencies and their consequences, including spina bifida and other neural tube defects, through safe and effective food fortification. May 2023 [internet publication].Full text
68. Mills JL, Signore CC. Folic acid and the prevention of neural tube defects. N Engl J Med. 2004 May 20;350(21):2209-11. Abstract
69. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. Sep 2017 [internet publication].Full text
70. Dwyer ER, Filion KB, MacFarlane AJ, et al. Who should consume high-dose folic acid supplements before and during early pregnancy for the prevention of neural tube defects? BMJ. 2022 Jun 7;377:e067728. Abstract
71. American College of Obstetricians and Gynecologists. Ultrasound in pregnancy. Dec 2016 [internet publication].Full text
72. Mehta TS, Levine D. Imaging of fetal cerebral ventriculomegaly: a guide to management and outcome. Semin Fetal Neonatal Med. 2005 Oct;10(5):421-8. Abstract
73. Blaicher W, Mittermayer C, Messerschmidt A. Fetal skeletal deformities - the diagnostic accuracy of prenatal ultrasonography and fetal magnetic resonance imaging. Ultraschall Med. 2004 Jun;25(3):195-9. Abstract
74. American College of Radiology; American College of Obstetricians and Gynecologists; American Institute of Ultrasound in Medicine; Society for Maternal Fetal Medicine; Society of Radiologists in Ultrasound. ACR-ACOG-AIUM-SMFM-SRU practice parameter for the performance of standard diagnostic obstetrical ultrasound. 2023 [internet publication].Full text
75. Norem CT, Schoen EJ, Walton DL, et al. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening. Obstet Gynecol. 2005 Oct;106(4):747-52. Abstract
76. Bruner JP, Tulipan N, Dabrowiak ME, et al. Upper level of the spina bifida defect: how good are we? Ultrasound Obstet Gynecol. 2004 Nov;24(6):612-7. Abstract
77. Chen CP. Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects. Taiwan J Obstet Gynecol. 2008 Sep;47(3):283-90.Full text Abstract
78. Spina Bifida Association. Guidelines for the care of people with spina bifida. 2018 [internet publication].Full text
79. American College of Obstetricians and Gynecologists. Practice bulletin no. 162: prenatal diagnostic testing for genetic disorders. Obstet Gynecol. 2016 May;127(5):e108-22. Abstract
80. Committee on Genetics and the Society for Maternal-Fetal Medicine. Committee opinion no.682: microarrays and next-generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology. Obstet Gynecol. 2016 Dec;128(6):e262-8.Full text Abstract
81. Janicki E, De Rademaeker M, Meunier C, et al. Implementation of exome sequencing in prenatal diagnostics: chances and challenges. Diagnostics (Basel). 2023 Feb 23;13(5):860.Full text Abstract
82. Zugazaga Cortazar A, Martín Martinez C, Duran Feliubadalo C, et al. Magnetic resonance imaging in the prenatal diagnosis of neural tube defects. Insights Imaging. 2013 Apr;4(2):225-37.Full text Abstract
83. Reddy UM, Abuhamad AZ, Levine D, et al; Fetal Imaging Workshop Invited Participants. Fetal imaging: Executive summary of a Joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop. Am J Obstet Gynecol. 2014 May;210(5):387-97. Abstract
84. Chao TT, Dashe JS, Adams RC, et al. Fetal spine findings on MRI and associated outcomes in children with open neural tube defects. AJR Am J Roentgenol. 2011 Nov;197(5):W956-61.Full text Abstract
85. Stevenson KL. Chiari type II malformation: past, present, and future. Neurosurg Focus. 2004 Feb 15;16(2):E5. Abstract
86. Dias MS. Neurosurgical management of myelomeningocele (spina bifida). Pediatr Rev. 2005 Feb;26(2):50-60. Abstract
87. Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011 Mar 17;364(11):993-1004.Full text Abstract
88. Pollack IF, Kinnunen D, Albright AL. The effect of early craniocervical decompression on functional outcome in neonates and young infants with myelodysplasia and symptomatic Chiari II malformations: results from a prospective series. Neurosurgery. 1996 Apr;38(4):703-10. Abstract
89. American College of Radiology; American Institute of Ultrasound in Medicine; Society for Pediatric Radiology; Society of Radiologists in Ultrasound. ACR-AIUM-SPR-SRU practice parameter for the performance of an ultrasound examination of the neonatal and infant spine. 2021 [internet publication].Full text
90. Joseph DB. Current approaches to the urologic care of children with spina bifida. Curr Urol Rep. 2008 Mar;9(2):151-7. Abstract
91. Frimberger D, Cheng E, Kropp BP. The current management of the neurogenic bladder in children with spina bifida. Pediatr Clin North Am. 2012 Aug;59(4):757-67. Abstract
92. Visconti D, Noia G, Triarico S, et al. Sexuality, pre-conception counseling and urological management of pregnancy for young women with spina bifida. Eur J Obstet Gynecol Reprod Biol. 2012 Aug;163(2):129-33. Abstract
93. Gunnett M, Rocque BG, Nourani A, et al. Impact of spina bifida on sleep quality: current insights. Nat Sci Sleep. 2023 Nov 24:15:967-78.Full text Abstract
94. Spina Bifida Association. Sleep related breathing disorders guideline [internet publication].Full text
95. Trivedi J, Thompson JD, Slakey JB, et al. Clinical and radiographic predictors of scoliosis in patients with myelomeningocele. J Bone Joint Surg Am. 2002 Aug;84(8):1389-94. Abstract
96. Tortori-Donati P, Fondellia MP, Rossia A, et al. Segmental spinal dysgenesis: neuroradiologic findings with clinical and embryologic correlation. AJNR Am J Neuroradiol. 1999 Mar;20(3):445-56.Full text Abstract
97. Ryan KD, Plosky C, Emans JB. Myelodysplasia - the musculoskeletal problem: habilitation from infancy to adulthood. Phys Ther. 1991 Dec;71(12):935-46. Abstract
98. Battibugli S, Gryfakis N, Dias L, et al. Functional gait comparison between children with myelomeningocele: shunt versus no shunt. Dev Med Child Neurol. 2007 Oct;49(10):764-9.Full text Abstract
99. Harstall C; Institute of Health Economics (Canada). First and second trimester prenatal screening for trisomies 13, 18, and 21 and open neural tube defects. Sep 2012 [internet publication].Full text
100. Cameron M, Moran P. Prenatal screening and diagnosis of neural tube defects. Prenat Diagn. 2009 Apr;29(4):402-11. Abstract
101. Tulipan N, Wellons JC 3rd, Thom EA, et al; MOMS Investigators. Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr. 2015 Dec;16(6):613-20.Full text Abstract
102. American College of Obstetricians and Gynecologists. Committee opinion no. 720: maternal-fetal surgery for myelomeningocele. 2017 Sep;130(3):e164-7.Full text Abstract
103. Spinner SS, Miesnik SR, Koh JG, et al. Maternal, fetal, and neonatal care in open fetal surgery for myelomeningocele. J Obstet Gynecol Neonatal Nurs. 2012 May-Jun;41(3):447-54. Abstract
104. Sacco A, Ushakov F, Thompson D, et al. Fetal surgery for open spina bifida. Obstet Gynaecol. 2019 Oct;21(4):271-82.Full text Abstract
105. Sanz Cortes M, Chmait RH, Lapa DA, et al. Experience of 300 cases of prenatal fetoscopic open spina bifida repair: report of the International Fetoscopic Neural Tube Defect Repair Consortium. Am J Obstet Gynecol. 2021 Dec;225(6):678.e1-11. Abstract
106. Blount JP, Bowman R, Dias MS, et al. Neurosurgery guidelines for the care of people with spina bifida. J Pediatr Rehabil Med. 2020;13(4):467-77.Full text Abstract
107. Swarup I, Talwar D, Howell LJ, et al. Orthopaedic outcomes of prenatal versus postnatal repair of myelomeningocele. J Pediatr Orthop B. 2022 Jan 1;31(1):87-92.Full text Abstract
108. Brock JW 3rd, Thomas JC, Baskin LS, et al. Effect of prenatal repair of myelomeningocele on urological outcomes at school age. J Urol. 2019 Oct;202(4):812-8. Abstract
109. Houtrow AJ, Thom EA, Fletcher JM, et al. Prenatal repair of myelomeningocele and school-age functional outcomes. Pediatrics. 2020 Feb;145(2):e20191544.Full text Abstract
110. Lingman G. Management of pregnancy and labour in cases diagnosed with major fetal malformation. Curr Opin Obstet Gynecol. 2005 Apr;17(2):143-6. Abstract
111. Shaer CM, Chescheir N, Erickson K, et al. Obstetrician-gynecologists' practice and knowledge regarding spina bifida. Am J Perinatol. 2006 Aug;23(6):355-62. Abstract
112. Church PT, Castillo H, Castillo J, et al. Prenatal counseling: guidelines for the care of people with spina bifida. J Pediatr Rehabil Med. 2020;13(4):461-6.Full text Abstract
113. Hassan K, Abouharb R, Mackieh R, et al. Does combining the placement of a ventriculoperitoneal shunt and repairing a myelomeningocele in new-borns impact the occurrence of complications? Jan 2024 [internet publication].Full text
114. Warf BC, Stagno V, Mugamba J. Encephalocele in Uganda: ethnic distinctions in lesion location, endoscopic management of hydrocephalus, and survival in 110 consecutive children. J Neurosurg Pediatr. 2011 Jan;7(1):88-93. Abstract
115. Vogel TW, Bahuleyan B, Robinson S, et al. The role of endoscopic third ventriculostomy in the treatment of hydrocephalus. J Neurosurg Pediatr. 2013 Jul;12(1):54-61. Abstract
116. Riva-Cambrin J, Kestle JRW, Rozzelle CJ, et al. Predictors of success for combined endoscopic third ventriculostomy and choroid plexus cauterization in a North American setting: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr. 2019 Aug 1;24(2):128-38.Full text Abstract
117. Jenkinson MD, Hayhurst C, Al-Jumaily M, et al. The role of ETV in adult patients with hydrocephalus. J Neurosurgery. 2009 May;110(5):861-6. Abstract
118. Drake JM, Kestle JR, Milner R, et al. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery. 1998 Aug;43(2):294-303. Abstract
119. National Institute of Neurological Disorders and Stroke. HCRN endoscopic versus shunt treatment of hydrocephalus in infants. Jul 2022 [internet publication].Full text
120. Joseph DB, Baum MA, Tanaka ST, et al. Urologic guidelines for the care and management of people with spina bifida. J Pediatr Rehabil Med. 2020;13(4):479-89.Full text Abstract
121. Franco I, Horowitz M, Grady R, et al. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction. J Urol. 2005 Jan;173(1):221-5. Abstract
122. Sturm RM, Cheng EY. The management of the pediatric neurogenic bladder. Curr Bladder Dysfunct Rep. 2016;11:225-33.Full text Abstract
123. Hopps CV, Kropp KA. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup. J Urol. 2003 Jan;169(1):305-8. Abstract
124. Dik P, Klijn AJ, van Gool JD, et al. Early start to therapy preserves kidney function in spina bifida patients. Eur Urol. 2006 May;49(5):908-13. Abstract
125. Swaroop VT, Dias L. Orthopaedic management of spina bifida-part II: foot and ankle deformities. J Child Orthop. 2011 Dec;5(6):403-14.Full text Abstract
126. Lorente Molto FJ, Martinez GI. Retrospective review of L3 myelomeningocele in three groups: should posterolateral iliopsoas transfer still be indicated to stabilize the hip? J Pediatr Orthop B. 2005 May;14(3):177-84. Abstract
127. Dias L. Hip dislocation in spina bifida: when is surgery required and what type of surgery should be performed? Ortop Traumatol Rehabil. 2011 Mar-Apr;13(2):101-3. Abstract
128. Ambartsumyan L, Rodriguez L. Bowel management in children with spina bifida. J Pediatr Rehabil Med. 2018;11(4):293-301. Abstract
129. Lindquist B, Carlsson G, Persson EK, et al. Learning disabilities in a population-based group of children with hydrocephalus. Acta Paediatr. 2005 Jul;94(7):878-83. Abstract
130. Lindquist B, Jacobsson H, Strinnholm M, et al. A scoping review of cognition in spina bifida and its consequences for activity and participation throughout life. Acta Paediatr. 2022 Sep;111(9):1682-94.Full text Abstract
131. Dennis M, Barnes MA. The cognitive phenotype of spina bifida meningomyelocele. Dev Disabil Res Rev. 2010;16(1):31-9.Full text Abstract
132. Kulesz PA, Treble-Barna A, Williams VJ, et al. Attention in spina bifida myelomeningocele: relations with brain volume and integrity. Neuroimage Clin. 2015 Mar 31:8:72-8.Full text Abstract
133. Wasserman RM, Stoner AM, Stern A, et al. ADHD and attention problems in children with and without spina bifida. Top Spinal Cord Inj Rehabil. 2016 Fall;22(4):253-9.Full text Abstract
134. Davidovitch M, Manning-Courtney P, Hartmann LA, et al. The prevalence of attentional problems and the effect of methylphenidate in children with myelomenigocele. Pediatr Rehabil. 1999 Jan-Mar;3(1):29-35. Abstract
135. Queally JT, Barnes MA, Castillo H, et al. Neuropsychological care guidelines for people with spina bifida. J Pediatr Rehabil Med. 2020;13(4):663-73.Full text Abstract
136. Davis BE, Shurtleff DB, Walker WO, et al. Acquisition of autonomy skills in adolescents with myelomeningocele. Dev Med Child Neurol. 2006 Apr;48(4):253-8.Full text Abstract
137. Dineen-Griffin S, Garcia-Cardenas V, Williams K, et al. Helping patients help themselves: a systematic review of self-management support strategies in primary health care practice. PLoS One. 2019 Aug 1;14(8):e0220116.Full text Abstract
138. Sawin KJ, Margolis RHF, Ridosh MM, et al. Self-management and spina bifida: a systematic review of the literature. Disabil Health J. 2021 Jan;14(1):100940.Full text Abstract
139. Peny-Dahlstrand M, Hofgren C, Lindquist B, et al. The Cognitive Orientation to daily Occupational Performance (CO-OP) approach is superior to ordinary treatment for achievement of goals and transfer effects in children with cerebral palsy and spina bifida: a randomized controlled trial. Disabil Rehabil. 2023 Mar;45(5):822-31.Full text Abstract
140. Öhrvall AM, Bergqvist L, Hofgren C, et al. "With CO-OP I'm the boss" - experiences of the cognitive orientation to daily occupational performance approach as reported by young adults with cerebral palsy or spina bifida. Disabil Rehabil. 2020 Dec;42(25):3645-52.Full text Abstract
141. Holbein CE, Lennon JM, Kolbuck VD, et al. Observed differences in social behaviors exhibited in peer interactions between youth with spina bifida and their peers: neuropsychological correlates. J Pediatr Psychol. 2015 Apr;40(3):320-35.Full text Abstract
142. Proos LA, Dahl M, Ahlsten G, et al. Increased perinatal intracranial pressure and prediction of early puberty in girls with myelomeningocele. Arch Dis Child. 1996 Jul;75(1):42-5.Full text Abstract
143. Dahl M, Proos LA, Ahlsten G, et al. Early puberty in boys with myelomeningocele. Eur J Pediatr Surg. 1997 Dec;7 Suppl 1:50. Abstract
144. Cholley F, Trivin C, Sainte-Rose C, et al. Disorders of growth and puberty in children with non-tumoral hydrocephalus. J Pediatr Endocrinol Metab. 2001 Mar;14(3):319-27. Abstract
145. Almutlaq N, O'Neil J, Fuqua JS. Central precocious puberty in spina bifida children: guidelines for the care of people with spina bifida. J Pediatr Rehabil Med. 2020;13(4):557-63.Full text Abstract
146. Hess MJ, Hough S. Impact of spinal cord injury on sexuality: broad-based clinical practice intervention and practical application. J Spinal Cord Med. 2012 Jul;35(4):211-8.Full text Abstract
147. Houtrow A, Roland M. Sexual health and education guidelines for the care of people with spina bifida. J Pediatr Rehabil Med. 2020;13(4):611-9.Full text Abstract
148. Bong GW, Rovner ES. Sexual health in adult men with spina bifida. ScientificWorldJournal. 2007 Sep 1;7:1466-9.Full text Abstract
149. Deng N, Thirumavalavan N, Beilan JA, et al. Sexual dysfunction and infertility in the male spina bifida patient. Transl Androl Urol. 2018 Dec;7(6):941-9.Full text Abstract
150. Conklin MJ, Kishan S, Nanayakkara CB, et al. Orthopedic guidelines for the care of people with spina bifida. J Pediatr Rehabil Med. 2020;13(4):629-35.Full text Abstract
151. US Preventive Services Task Force; Mangione CM, Barry MJ, Nicholson WK, et al. Screening for obstructive sleep apnea in adults: US Preventive Services Task Force Recommendation statement. JAMA. 2022 Nov 15;328(19):1945-50.Full text Abstract
152. Holmbeck GN, Kritikos TK, Stern A, et al. The transition to adult health care in youth with spina bifida: theory, measurement, and interventions. J Nurs Scholarsh. 2021 Mar;53(2):198-207.Full text Abstract
153. Fremion E, Kaufman M, Mukherjee S, et al. 2023 updates to the spina bifida transition to adult care guidelines. J Pediatr Rehabil Med. 2023;16(4):583-93.Full text Abstract
154. Hopson B, MSHA, Alford EN, et al. Development of an evidence-based individualized transition plan for spina bifida. Neurosurg Focus. 2019 Oct 1;47(4):E17.Full text Abstract
155. Liptak GS, Garver K, Dosa NP. Spina bifida grown up. J Dev Behav Pediatr. 2013 Apr;34(3):206-15. Abstract
156. Webb TS. Medical care of adults with spina bifida. J Pediatr Rehabil Med. 2009;2(1):3-11. Abstract
157. Webb TS. Optimizing health care for adults with spina bifida. Dev Disabil Res Rev. 2010;16(1):76-81. Abstract
158. Dicianno BE, Gaines A, Collins DM, et al. Mobility, assistive technology use, and social integration among adults with spina bifida. Am J Phys Med Rehabil. 2009 Jul;88(7):533-41. Abstract
159. Dicianno BE, Wilson R. Hospitalizations of adults with spina bifida and congenital spinal cord anomalies. Arch Phys Med Rehabil. 2010 Apr;91(4):529-35. Abstract
160. Simon TD, Lamb S, Murphy NA, et al. Who will care for me next? Transitioning to adulthood with hydrocephalus. Pediatrics. 2009 Nov;124(5):1431-7.Full text Abstract
161. Verhoef M, Lurvink M, Barf HA, et al. High prevalence of incontinence among young adults with spina bifida: description, prediction and problem perception. Spinal Cord. 2005 Jun;43(6):331-40.Full text Abstract
162. Palmer JS, Kaplan WE, Firlit CF. Erectile dysfunction in patients with spina bifida is a treatable condition. J Urol. 2000 Sep;164(3 Pt 2):958-61. Abstract
163. World Allergy Organization. Latex allergy diagnosis and management. Jan 2022 [internet publication].Full text
164. Arata M, Grover S, Dunne K, et al. Pregnancy outcome and complications in women with spina bifida. J Reprod Med. 2000 Sep;45(9):743-8. Abstract
165. Garcia AM, Dicianno BE. The frequency of lymphedema in an adult spina bifida population. Am J Phys Med Rehabil. 2011 Feb;90(2):89-96. Abstract
166. Valtonen KM, Goksör LA, Jonsson O, et al. Osteoporosis in adults with meningomyelocele: an unrecognized problem at rehabilitation clinics. Arch Phys Med Rehabil. 2006 Mar;87(3):376-82. Abstract
167. Dosa NP, Eckrich M, Katz DA, et al. Incidence, prevalence, and characteristics of fractures in children, adolescents, and adults with spina bifida. J Spinal Cord Med. 2007;30 Suppl 1:S5-9.Full text Abstract
168. Stepanczuk BC, Dicianno BE, Webb TS. Young adults with spina bifida may have higher occurrence of prehypertension and hypertension. Am J Phys Med Rehabil. 2014 Mar;93(3):200-6. Abstract
169. Dagenais LM, Lahay ER, Stueck KA, et al. Effects of electrical stimulation, exercise training and motor skills training on strength of children with meningomyelocele: a systematic review. Phys Occup Ther Pediatr. 2009;29(4):445-63. Abstract
170. Wang Y, Liu G, Canfield MA, et al; National Birth Defects Prevention Network. Racial/ethnic differences in survival of United States children with birth defects: a population-based study. J Pediatr. 2015 Apr;166(4):819-26.Full text Abstract
171. Moore CA, Li S, Li Z, et al. Elevated rates of severe neural tube defects in a high prevalence area of Northern China. Am J Med Genet. 1997 Dec 12;73(2):113-8. Abstract
172. Botto LD, Moore CA, Khoury MJ, et al. Neural tube defects. N Engl J Med. 1999 Nov 11;341(20):1509-19. Abstract
173. Sutton M, Daly LE, Kirke PN. Survival and disability in a cohort of neural tube defect births in Dublin, Ireland. Birth Defects Res A Clin Mol Teratol. 2008 Oct;82(10):701-9. Abstract
174. Barf HA, Post MW, Verhoef M, et al. Restrictions in social participation of young adults with spina bifida. Disabil Rehabil. 2009;31(11):921-7. Abstract
175. Moore C, Kogan BA, Parekh A. Impact of urinary incontinence on self-concept in children with spina bifida. J Urol. 2004 Apr;171(4):1659-62. Abstract
176. Liptak GS, Kennedy JA, Dosa NP. Youth with spina bifida and transitions: health and social participation in a nationally represented sample. J Pediatr. 2010 Oct;157(4):584-8. Abstract
177. Oakeshott P, Hunt GM, Poulton A, et al. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol. 2010 Aug;52(8):749-53.Full text Abstract
178. Bowman RM, McLone DG, Grant JA, et al. Spina bifida outcome: a 25-year perspective. Pediatr Neurosurg. 2001 Mar;34(3):114-20. Abstract
179. Davis BE, Daley CM, Shurtleff DB, et al. Long-term survival of individuals with myelomeningocele. Pediatr Neurosurg. 2005 Jul-Aug;41(4):186-91. Abstract
180. Shin M, Besser LM, Correa A. Prevalence of spina bifida among children and adolescents in metropolitan Atlanta. Birth Defects Res A Clin Mol Teratol. 2008 Nov;82(11):748-54. Abstract
181. Ouyang L, Grosse SD, Armour BS, et al. Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Res A Clin Mol Teratol. 2007 Jul;79(7):552-8. Abstract
182. Bamer AM, Connell FA, Dudgeon BJ, et al. Frequency of purchase and associated costs of assistive technology for Washington State Medicaid program enrollees with spina bifida by age. Disabil Health J. 2010 Jul;3(3):155-61. Abstract
183. Clayton DB, Brock JW 3rd. The urologist's role in the management of spina bifida: a continuum of care. Urology. 2010 Jul;76(1):32-8. Abstract
184. Piatt JH Jr. Treatment of myelomeningocele: a review of outcomes and continuing neurosurgical considerations among adults. J Neurosurg Pediatr. 2010 Dec;6(6):515-25. Abstract
185. Meeropol E. Latex allergy update: clinical practice and unresolved issues. J Wound Ostomy Continence Nurs. 1996 Jul;23(4):193-6. Abstract
186. Nieto A, Mazon A, Pamies R, et al. Efficacy of latex avoidance for primary prevention of latex sensitization in children with spina bifida. J Pediatrics. 2002 Mar;140(3):370-2. Abstract
187. Cremer R, Kleine-Diepenbruck U, Hering F, et al. Reduction of latex sensitization in spina bifida patients by a primary prophylaxis programme (five years experience). Eur J Pediatr Surg. 2002 Dec;12 Suppl 1:S19-21. Abstract
188. Mazon A, Nieto A, Linana JJ, et al. Latex sensitization in children with spina bifida: follow up comparative study after two years. Ann Allergy Asthma Immunol. 2000 Feb;84(2):207-10. Abstract
189. Casteels K, Fieuws S, van Helvoirt M, et al. Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. Pediatr Diabetes. 2010 Feb;11(1):61-9. Abstract
190. Hertzler DA 2nd, DePowell JJ, Stevenson CB, et al. Tethered cord syndrome: a review of the literature from embryology to adult presentation. Neurosurg Focus. 2010 Jul;29(1):E1. Abstract
191. Filippidis AS, Kalani MY, Theodore N, et al. Spinal cord traction, vascular compromise, hypoxia, and metabolic derangements in the pathophysiology of tethered cord syndrome. Neurosurg Focus. 2010 Jul;29(1):E9. Abstract
192. Shih P, Halpin RJ, Ganju A, et al. Management of recurrent adult tethered cord syndrome. Neurosurg Focus. 2010 Jul;29(1):E5. Abstract
193. Dicianno BE, Kurowski BG, Yang JM, et al. Rehabilitation and medical management of the adult with spina bifida. Am J Phys Med Rehabil. 2008 Dec;87(12):1027-50. Abstract
194. Clayton DB, Brock JW 3rd, Joseph DB. Urologic management of spina bifida. Dev Disabil Res Rev. 2010;16(1):88-95. Abstract
195. Ok JH, Kurzrock EA. Objective measurement of quality of life changes after ACE Malone using the FICQOL survey. J Pediatr Urol. 2011 Jun;7(3):389-93.Full text Abstract
196. Aurora RN, Zak RS, Karippot A, et al. Practice parameters for the respiratory indications for polysomnography in children. Sleep. 2011 Mar 1;34(3):379-88.Full text Abstract
197. Edelstein K, Cirino PT, Hasher L, et al. Sleep problems, chronotype, and diurnal preferences in children and adults with spina bifida. J Biol Rhythms. 2012 Apr;27(2):172-5. Abstract
198. Thomson JD, Segal LS. Orthopedic management of spina bifida. Dev Disabil Res Rev. 2010;16(1):96-103. Abstract
Use of this content is subject to our disclaimer